A phase 3, open-label, parallel group treatment concordance study to compare insulin use and its effect on glycemic control in patients with type 2 diabetes mellitus: two populations with different insulin treatment options

Trial Profile

A phase 3, open-label, parallel group treatment concordance study to compare insulin use and its effect on glycemic control in patients with type 2 diabetes mellitus: two populations with different insulin treatment options

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Jan 2008 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top